Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
28 participants
INTERVENTIONAL
2020-11-01
2020-12-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Influence of Probiotics on Clinical Parameters, the Oral Microbiome and the Immune System During an Orthodontic Treatment in Adult Patients
NCT04606186
Influence of Probiotics on Clinical Parameters, the Oral Microbiome and the Immune System During an Orthodontic Treatment
NCT04598633
Using Probiotics to Improve Oral Hygiene During Orthodontic Treatment
NCT06641960
The Effect of Oral Probiotics on Oral Hygiene and Halitosis in Orthodontic Patients.
NCT05651503
Evaluation of the Effect of a Probiotic in Patients Undergoing Orthodontic Therapy
NCT06752330
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The null-hypothesis is that: The effect of probiotics would not differ from placebo-treated control group.
This product might decrease the chance of getting caries but also cooperation and cost effectiveness should be considered
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Active Probiotic
Probiotic contain active microorganism
Active Probiotic
Lactobacillus Reuteri (DSM 17938 and ATCC PTA 4659
Placebo Probiotic
Probiotic with no active microorganism
Placebo Probiotic
Placebo
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Active Probiotic
Lactobacillus Reuteri (DSM 17938 and ATCC PTA 4659
Placebo Probiotic
Placebo
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Number of S. mutans counts (\>10.000 CFU/ml)
* Permanent dentition
* 3-12 months into the treatment (study from Sweden by Andrea)
* Medically healthy
* Not taking any medication
* Ability to understand the nature of the study and sign the consent form
Exclusion Criteria
* Systemic diseases or conditions that could interfere with our study (diabetes, immunosuppression diseases, pregnancy or ongoing therapy).
* History of probiotics/anti-inflammatory drugs taken during the last 4 weeks prior to baseline examination
* Local or general antimicrobial substances taken during the last 4 prior weeks prior to baseline examination
* Habitual consumers of xylitol chewing gums
* No active or untreated carious lesions and reported daily tooth brushing habit using fluoridated toothpaste
14 Years
30 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Göteborg University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Gothenburg university
Gothenburg, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Alforaidi S, Bresin A, Almosa N, Lehrkinder A, Lingstrom P. Effect of drops containing Lactobacillus reuteri (DSM 17938 and ATCC PTA 5289) on plaque acidogenicity and other caries-related variables in orthodontic patients. BMC Microbiol. 2021 Oct 6;21(1):271. doi: 10.1186/s12866-021-02310-2.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
260-20
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.